Christian Behrenbruch

Christian Behrenbruch

Fortune : 236 M $ au 31/08/2026

51 ans
Health Technology
Consumer Services
Non-Energy Minerals

Profil

Christian P.
Behrenbruch
is the founder of Telix Pharmaceuticals Ltd., founded in 2015, holding the titles of Group CEO, MD & Executive Director.
Dr. Behrenbruch was the founder of ImaginAb, Inc., founded in 2007, serving as Chief Executive Officer & Director.
Dr. Behrenbruch is also the founder of Amplia Therapeutics Pty Ltd...
Current positions include Chairman at Monash Engineering Foundation, Managing Director at Irukandji Research Pty Ltd., and Director at Telix Innovations SA (Belgium) since 2018.
Former positions include Chief Executive Officer at Fibron Technologies, Inc. (2008–2011), Chief Executive Officer at Mirada Solutions Ltd. (2001–2002), Chairman at Cell Therapies Pty Ltd. (2012–2014), Non-Executive Director at Invert Graphite Ltd. (2017–2021), Director at Oncidium Foundation, Independent Director at Amplia Therapeutics Ltd. (2018–2020), Director at Siemens Molecular Imaging, Inc. (2005–2006), Director at Momentum Biosciences LLC (2007–2009), Director at Radius Health, Inc. (2009–2011), and President at CTI Molecular Imaging, Inc. (2003–2006).
Education includes graduate degree from the University of Melbourne, doctorate from the University of Oxford, MBAistration from New York University, and MBAistration from École des Hautes Études Commerciales de Paris.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/05/2026 21 396 941 ( 6,3% ) 236 M $ 31/08/2026

Postes actifs de Christian Behrenbruch

SociétésPosteDébut
TELIX PHARMACEUTICALS LIMITED Fondateur 01/11/2015
Directeur/Membre du Conseil 21/12/2018
Fondateur -
Irukandji Research Pty Ltd.
Corporate Officer/Principal -
Monash Engineering Foundation
Président -

Anciens postes connus de Christian Behrenbruch

SociétésPosteFin
INVERT GRAPHITE LIMITED Directeur/Membre du Conseil 28/05/2021
AMPLIA THERAPEUTICS LIMITED Directeur/Membre du Conseil 01/02/2020
Fondateur 01/02/2015
Cell Therapies Pty Ltd.
Président 01/07/2014
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Christian Behrenbruch

Formation de Christian Behrenbruch

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Health Technology

Non-Energy Minerals

Health Technology

Consumer Services

Consumer Services

Technology Services

Consumer Services

Consumer Services

Cell Therapies Pty Ltd.

Siemens Molecular Imaging, Inc.

Process Industries

Health Technology

Finance

Health Technology

Monash Engineering Foundation

Oncidium Foundation

Irukandji Research Pty Ltd.

Health Technology

Distribution Services

Health Technology

  1. Bourse
  2. Insiders
  3. Christian Behrenbruch
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT